When compared to healthy individuals, SSc patients were also found to present significantly elevated levels of the soluble form of the oncostatin M receptor (sOSMR), which has been thought to act as an antagonist of the IL-6 family-belonging oncostatin M [151]. The gene discussed is IL6; the disease is systemic sclerosis.